Differential impact of proton pump inhibitors and antibiotics on immunotherapy efficacy after chemoradiotherapy in local…
この記事を読む
記事一覧
この記事を読む
TIGIT抗体とPD-L1阻害薬との併用効果はあまりない
SKYSCRAPER-01: Tiragolumab in Combination With Atezolizumab in Previously Untreated PD-L1-High, Locally Advanced, Unrese…
この記事を読む
胸水例に対するラムシルマブ＋エルロチニブ
Phase II study of ramucirumab plus erlotinib for treatment-naïve patients with EGFR-mutant non-squamous non-small cell l…
この記事を読む
TTF-1発現と治療効果との包括的検討
TTF-1 Expression in Lung Adenocarcinoma: Clinicopathologic, Genomic, and Immunophenotypic Correlates and Outcomes to Imm…
この記事を読む
悪性胸膜中皮腫に対する免疫2剤→プラチナ＋ペメトレキセドの有効性
Outcomes of Platinum Plus Pemetrexed and Treatment Patterns Following First-Line Nivolumab and Ipilimumab in Pleural Mes…
この記事を読む
ICI治療2年完遂後のフォローアップはどうあるべきか
Consensus recommendations on surveillance and survivorship for patients with unresectable/stage IV non-small cell lung c…
この記事を読む
PD-1とVEGFを標的とする二重抗体と扁平上皮癌
Ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy in advanced squamous non-small-cell lung cancer (HAR…
この記事を読む
Exon20挿入変異に対する初回サンボゼルチニブ
First-Line Sunvozertinib in NSCLC with EGFR Exon20 Insertion Mutations. Zhou C et al.N Engl J Med. 2026 May 29. Epub ahe…
この記事を読む
TROP-2標的のADCとペムブロリズマブ併用
Sacituzumab tirumotecan plus pembrolizumab versus pembrolizumab in PD-L1-positive advanced non-small-cell lung cancer (O…
この記事を読む
EGFR遺伝子変異陽性例に脳転移局所療法の利益は証明できず
Osimertinib and Stereotactic Radiosurgery for Brain Metastases in EGFR-Mutated Lung Cancer: The STARLET Joint Analysis o…